New Delhi: Omu kugarukamu ekiteiso kya Fresenius Medical Care, akakiiko k’abakugu ab’omutaano (SEC) ak’ekitongore ky’okurinda emibazi (CDSCO) kahabura kampuni kuhayo enshonga y’okugiikiriza hamwe n’ebihandiiko by’okucondooza eby’omurundi gwa kashatu eby’okucondooza eby’okukoresa omu kucondooza kwa calcium chlorilla dihydrate- okuteekateekaho.
Kampuni egi ekaba yaabanza yaataho okushaba kw’okukora n’okuguza omubazi gwa calcium chloride dihydrate aha nkora ya 100 mmol/L, ogurikukoresibwa “okujanjaba okugaruzaho calcium omu kujanjaba okurikugumizamu okurikugaruzaho ebihaha (CRRT), okujanjaba okurikugumizamu okutarimu amaani makye (buri izooba) okukyebera (CLED) n’ekirungo kya citragute exchange plasma. ekihikire aha bantu bakuru n‘abaana” kandi yaagamba enshonga z‘okuruga omu kucondooza kw‘eby‘amagara okwa phase III na phase IV.
Akakiiko aka kashangire ngu ekintu eki kikaikiriziibwe omu mahanga ga Buraaya nka Portugal, Bungyereza, Brazil, Switzerland, France na Denmark.
Ekirungo kya kalsiyumu kloridi dihydrate ni CaCl2 2H2O, ekirimu kalsiyumu kloridi erimu molekyu ibiri z’amaizi ahari buri yuniiti ya kalsiyumu kloridi. Ni ekintu ekirikwera ekiri nk’ekibiriiti, ekirikubaasa kusheesheka juba omu maizi kandi ekirikubaasa kunywa obutagatsi kuruga omu mwanya.
Calcium chloride dihydrate n’ekirungo ekirikubaasa kukoresibwa nk’omuringo gw’okusheenya ekirungo kya chitin kyaba nikisheesheka omu methanol. Nikikora omurimo muhango omu kuhenda omutindo gw’ekibiriiti kya chitin kandi kiine emirimo mingi omu by’obuhangwa.
Omu rukiiko rwa SEC Nephrology orwabaireho ebiro 20.05.2025, akakiiko kakashwijuma ekiteiso ky‘okwikirizibwa okukora n‘okuguza omubazi gw‘okuta omu mubiri ogwa 100 mmol/L ogw‘okukoresa omu “kujanjaba okurikugaruzaho calcium omu kujanjaba okurikugumizamu (CRLEdai-efficiency) n‘okujanjaba okurikugumizamu (CRLEdaiSRT) . okuhindura plasma y‘okujanjaba (TPE) n‘omubazi gw‘okuzibira okusheeshasheesha kw‘eshagama (citrate anticoagulation).
Bwanyima y’okugaaniira munonga, akakiiko kakahabura ngu omusingi gw’okwikirizibwa, hamwe n’ebihandiiko by’okucondooza eby’omurundi gwa kashatu (phase III clinical trial data) n’ebihandiiko by’okucondooza bwanyima y’okuguta omu katare kuruga omu mahanga agaikiriize omubazi ogu, biheebwa akakiiko kubaasa kugaruka kuguteekateekaho.
Shoma kandi: Ekibiina kya CDSCO kiikiriza okuhandiika okusya aha Myozyme ya Sanofi, Kishabire okushwijuma ebiragiro
Dr. Divya Kolin n'omushomesa wa PharmD kandi aine obumanyi bwingi omu by'obujanjabi n'amarwariro kandi aine obukugu burungi omu kukyebera n'okujanjaba. Kandi atwire nakora nk’omubazi gw’endwara z’ebihaha omu kitongore ky’eby’amagara g’abantu omu itendekyero ry’eby’obujanjabi erya Mysore Medical College n’okucondooza. Obwahati ariyo nakora omurimo gwe omu kucondooza aha by’obujanjabi n’okurinda amakuru g’obujanjabi. Abaire nakora na Medical Dialogue kuruga omukwamwenda 2022.
       Dr Kamal Kant Kohli, MBBS, MD, CP, is a thoracic specialist with over 30 years of experience and specializes in clinical writing. He joins Medical Dialogues as the Editor-in-Chief of Medical News. Apart from writing articles, as the Editor, he is responsible for proofreading and reviewing all medical content published in Medical Dialogues, including content from journals, research papers, medical conferences, guidelines, etc. Email: drkohli@medicaldialogues.in Contact: 011-43720751
Okucondooza kwa ABYSS kukashanga ngu okwemereza emibazi ya beta-blockers bwanyima y‘okuhutaara kw‘omutima kikarugamu okweyongyera kwa puresha, okuteera kw‘omutima, n‘ebintu bibi ebirikubaho omu mutima: ...